Profile
| Metric | Value |
|---|---|
| Full Name | Liquidia Corporation |
| Ticker | NASDAQ: LQDA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | liquidia.com |
| Employees | 170 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $41.07 | |
| Price, 1D Change | +2.70% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.12 | |
| Revenue | $14M | |
| Revenue, 1Y Change | -19.97% | |
| EPS | -$1.66 | |
| EPS, 1Y Change | -37.17% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.66 | |
| EPS Estimate | -$0.68 | |
| EPS Est. Change | +58.95% | |
| Revenue | $14.00M | |
| Revenue Estimate | $150.03M | |
| Revenue Est. Change | +971.95% | |
| Current Price | $41.07 | |
| Price Target | - | $49.00 |
| Price Tgt. Change | - | +19.31% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.02 | -$1.21 | -18.41% | |
| - | -$1.66 | - | |
| -$0.68 | N/A | +58.95% | |
| $2.69 | N/A | +262.61% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $17.69M | $17.49M | -1.14% | |
| $15.80M | $14.00M | -11.44% | |
| $150.03M | N/A | +971.95% | |
| $478.83M | N/A | +3,321.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +185.21% | |
| Price, 3Y | +534.78% | |
| Market Cap, 1Y | +193.00% | |
| Market Cap, 3Y | +755.93% | |
| Revenue, 1Y | -19.97% | |
| Revenue, 3Y | -9.75% | |
| EPS, 1Y | -37.17% | |
| EPS, 3Y | -138.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $41.07 | |
| SMA 200 | $22.88 | |
| SMA 200 vs Price | -44.28% | |
| SMA 50 | $33.29 | |
| SMA 50 vs Price | -18.94% | |
| Beta | 1.12 | |
| ATR | $2.65 | |
| 14-Day RSI | 68.38 | |
| 10-Day Volatility | 69.06% | |
| 1-Year Volatility | 65.31% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.00M | |
| EPS | -$1.66 | |
| Gross Profit | $8.12M | |
| Gross Margin | 58.00% | |
| Operating Profit | -$121.29M | |
| Operating Margin | -866.63% | |
| Net Income | -$130.39M | |
| Net Margin | -931.65% | |
| EBITDA | -$115.71M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.49 | |
| Current Ratio | 4.43 | |
| Quick Ratio | 4.42 | |
| Interest Coverage | -9.44 | |
| F-Score | 3 | |
| Altman Z-Score | 9.52 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 51.62 | |
| PB Ratio | 162.02 | |
| EV/EBITDA | -34.25 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $77.28M | |
| Cash & Equivalents | $176.48M | |
| Total Assets | $233.17M | |
| Current Assets | $185.11M | |
| Total Liabilities | $155.89M | |
| Current Liabilities | $41.78M | |
| Total Debt | $122.39M | |
| Short Term Debt | $18.43M | |
| Accounts Payable | $4.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $135.29M | |
| Operating Expenses | $129.41M | |
| Cost Of Goods Sold | $5.88M | |
| SG&A | $81.57M | |
| D&A | $2.20M | |
| Interest Expense | $12.49M | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$93.42M | |
| CFI | -$8.44M | |
| CFF | $194.66M | |
| Capex | $8.45M | |
| Free Cash Flow | -$101.87M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Scotiabank | ||
| LifeSci Capital | ||
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| B of A Securities | → | |
| Raymond James | → | |
| Needham | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with LQDA
FAQ
What is the ticker symbol for Liquidia Corporation?
The ticker symbol for Liquidia Corporation is NASDAQ:LQDA
Does Liquidia Corporation pay dividends?
No, Liquidia Corporation does not pay dividends
What sector is Liquidia Corporation in?
Liquidia Corporation is in the Healthcare sector
What industry is Liquidia Corporation in?
Liquidia Corporation is in the Biotechnology industry
What country is Liquidia Corporation based in?
Liquidia Corporation is headquartered in United States
When did Liquidia Corporation go public?
Liquidia Corporation initial public offering (IPO) was on July 26, 2018
Is Liquidia Corporation in the S&P 500?
No, Liquidia Corporation is not included in the S&P 500 index
Is Liquidia Corporation in the NASDAQ 100?
No, Liquidia Corporation is not included in the NASDAQ 100 index
Is Liquidia Corporation in the Dow Jones?
No, Liquidia Corporation is not included in the Dow Jones index
When was Liquidia Corporation last earnings report?
Liquidia Corporation's most recent earnings report was on November 3, 2025
When does Liquidia Corporation report earnings?
The next expected earnings date for Liquidia Corporation is February 26, 2026
Data Sources & References
- LQDA Official Website www.liquidia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1819576/000110465925105215/0001104659-25-105215-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1819576/000155837025006838/0001558370-25-006838-index.htm
- LQDA Profile on Yahoo Finance finance.yahoo.com/quote/LQDA
- LQDA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lqda